Form 8-K ARRAY BIOPHARMA INC For: Jan 29

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 10/23/2026

1. META
2. TSLA
3. IBM
4. TXN
5. MRNA
6. SAP
7. MRK
8. LVS
9. CSX
10. LRCX

Go back to Form 8-K ARRAY BIOPHARMA INC For: Jan 29

Array Biopharma (ARRY) Tops Q2 EPS by 12c; CFO Resigns; Updates on Novartis Agreement

February 3, 2015 8:08 AM EST

Array Biopharma (NASDAQ: ARRY) reported Q2 EPS of ($0.06), $0.12 better than the analyst estimate of ($0.18). Revenue for the quarter came in at $26.92 million versus the consensus estimate of $10.2 million.

Array announced today that Michael Carruthers, Chief Financial Officer (CFO), will be leaving Array to pursue an opportunity in the biopharmaceutical industry. The board and executive team thank Mr. Carruthers for his leadership and contributions to the success of Array. Dave Horin, CPA, a managing partner at Chord Advisers, has been appointed as interim CFO, and a search is underway for a CFO replacement to... More